# Vesalius Longevity Labs Inc.: Form D capital raise (Vancouver, A1)

**Vendor Spend Propensity Score (CPA / Tax / Audit):** 83/100
**Estimated post-raise budget for this service type:** $602,250 (heuristic)

| Field | Value |
|---|---|
| Industry | Pharmaceuticals (Healthcare & Life Sciences) |
| Operating company | Yes |
| Exemption | 506(b) |
| Amount sold | $30,112,500 |
| Total offering | $30,112,500 |
| Investors so far | 62 |
| First sale | 2026-10-28 |
| Filed | 2026-11-03 |
| Entity | Corporation |

## Executives and related persons (as listed in the filing)
- PRADEEP ALBERT: Executive Officer
- CHRISTOPHER R COOPER: Executive Officer
- TIMMI STUMP: Executive Officer
- JAMES MCROBERTS: Director
- KEVIN SERRE: Director
- ROBERT MCCUE: Director
- JOEL LEONOFF: Director
- KEVIN MAYER: Director
- DAVID ADELMAN: Director
- LEE APPLBAUM: Director

## Why this score
- Operating company: new capital typically funds hiring, facilities and vendors.
- Raised $30,112,500 so far: a large raise.
- Healthcare & Life Sciences companies are a strong fit for CPA / Tax / Audit services.
- New filing (not an amendment): the raise is fresh.
- Filed 1 day ago.

Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) (https://www.sec.gov/Archives/edgar/data/2131865/000206075526000064/). Last refreshed: 2026-11-04T01:28:40.459Z.
Informational only. SEC EDGAR Form D data is shown for business-development research; it is not investment advice and not an offer or solicitation to buy or sell any security. Not legal or financial advice.